187 related articles for article (PubMed ID: 26420914)
1. Serum and Vitreous Concentrations of Omentin-1 in Diabetic Retinopathy.
Wan W; Li Q; Zhang F; Zheng G; Lv Y; Wan G; Jin X
Dis Markers; 2015; 2015():754312. PubMed ID: 26420914
[TBL] [Abstract][Full Text] [Related]
2. Serum and vitreous levels of visfatin in patients with diabetic retinopathy.
Wang Y; Yuan Y; Jiang H
Med Sci Monit; 2014 Dec; 20():2729-32. PubMed ID: 25524991
[TBL] [Abstract][Full Text] [Related]
3. Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy.
Zhao C; Hou J; Wang S; Jiang R
Med Sci Monit; 2015 Jun; 21():1839-42. PubMed ID: 26110737
[TBL] [Abstract][Full Text] [Related]
4. Relation of serum and vitreous nesfatin-1 concentrations with diabetic retinopathy.
Dai R; Deng G; Sun Z; Liu Z; Qian Y; Han Y
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 28079928
[TBL] [Abstract][Full Text] [Related]
5. Serum and Vitreous Pentraxin 3 Concentrations in Patients with Diabetic Retinopathy.
Zhou W; Hu W
Genet Test Mol Biomarkers; 2016 Mar; 20(3):149-53. PubMed ID: 26836044
[TBL] [Abstract][Full Text] [Related]
6. Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.
Tian M; Wang J; Wei Y; Lu Q; Huang B
J Investig Med; 2016 Oct; 64(7):1209-12. PubMed ID: 27422995
[TBL] [Abstract][Full Text] [Related]
7. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
8. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574
[TBL] [Abstract][Full Text] [Related]
9. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
10. Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients.
Takeuchi M; Sato T; Tanaka A; Muraoka T; Taguchi M; Sakurai Y; Karasawa Y; Ito M
PLoS One; 2015; 10(9):e0137358. PubMed ID: 26352837
[TBL] [Abstract][Full Text] [Related]
11. Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.
Gustavsson C; Agardh CD; Agardh E
Acta Ophthalmol; 2013 Aug; 91(5):445-52. PubMed ID: 22520269
[TBL] [Abstract][Full Text] [Related]
12. Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy.
Qiu F; He J; Zhou Y; Bai X; Wu G; Wang X; Liu Z; Chen Y; Ma JX; Liu Z
Eye (Lond); 2014 Apr; 28(4):402-9. PubMed ID: 24406409
[TBL] [Abstract][Full Text] [Related]
13. Association of serum omentin-1, apelin and chemerin concentrations with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus patients.
Yasir M; Senthilkumar GP; Jayashree K; Ramesh Babu K; Vadivelan M; Palanivel C
Arch Physiol Biochem; 2022 Apr; 128(2):313-320. PubMed ID: 31686535
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.
Boss JD; Singh PK; Pandya HK; Tosi J; Kim C; Tewari A; Juzych MS; Abrams GW; Kumar A
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5594-5603. PubMed ID: 29084332
[TBL] [Abstract][Full Text] [Related]
15. Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy.
Jiang H; Du J; He T; Qu J; Song Z; Wu S
Clin Exp Ophthalmol; 2014 Dec; 42(9):841-5. PubMed ID: 24645972
[TBL] [Abstract][Full Text] [Related]
16. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease.
Tekce H; Tekce BK; Aktas G; Alcelik A; Sengul E
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):451-6. PubMed ID: 24918534
[TBL] [Abstract][Full Text] [Related]
17. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.
Zhou J; Wang S; Xia X
Curr Eye Res; 2012 May; 37(5):416-20. PubMed ID: 22409294
[TBL] [Abstract][Full Text] [Related]
18. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy.
Shahulhameed S; Vishwakarma S; Chhablani J; Tyagi M; Pappuru RR; Jakati S; Chakrabarti S; Kaur I
Front Immunol; 2020; 11():154. PubMed ID: 32117292
[TBL] [Abstract][Full Text] [Related]
20. Effect of Circulating Omentin-1 on the Retinal Circulation in Patients With Type 2 Diabetes Mellitus.
Omae T; Nagaoka T; Yoshida A
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5086-5092. PubMed ID: 28983564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
